solifenacin succinate
solifenacin succinate is listed in the FDA National Drug Code directory with 20 NDC codes, marketed under brand names including solifenacin succinate, Solifenacin succinate, VESIcare LS. Available dosage forms: tablet, film coated, powder, suspension, tablet, coated, tablet, film coated, extended release.
Drug Details
- Generic Name
- solifenacin succinate
- Brand Names
- solifenacin succinate, Solifenacin succinate, VESIcare LS, Solifenacin Succinate, VESIcare
- Application Number
- ANDA215761
- Sponsor
- Camber Pharmaceuticals, Inc.
- NDC Codes
- 20
- Dosage Forms
- TABLET, FILM COATED, POWDER, SUSPENSION, TABLET, COATED, TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- SOLIFENACIN SUCCINATE
Indications and Usage
1 INDICATIONS AND USAGE Solifenacin Succinate Tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin Succinate Tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )